Skip to content

← All news

Markets

AnaptysBio stock rating maintained at Outperform by Wolfe Research

1 source ·2 articles ·Aug 31, 15:44 UTC Anaptysbio

Covered by 1 outlet

All coverage · 2 articles

Investing.com Canada ·Aug 31, 15:44 UTC

Wolfe Research reiterates Protagonist Therapeutics stock rating at outperform

Investing.com UK ·Aug 31, 10:26 UTC

AnaptysBio stock rating maintained at Outperform by Wolfe Research